Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-096741·Coastlands Capital LP
Schedule 13G ownership disclosure
X4 Pharmaceuticals Inc
Common Stock, par value $0.001 per share · CUSIP: 98420X202
Event date: 2025-10-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Coastlands Capital LP
Shares: 2,491,638.00 · Class: 9.99%
- Coastlands Capital Partners LP
Shares: 2,491,638.00 · Class: 9.99%
- Coastlands Capital GP LLC
Shares: 2,491,638.00 · Class: 9.99%
- Coastlands Capital LLC
Shares: 2,491,638.00 · Class: 9.99%
- Matthew D. Perry
Shares: 2,491,638.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-096741
- Form type
- SCHEDULE 13G
- Filer
- Coastlands Capital LP
- CIK
- CIK 2068530
- Filed
- Oct 03, 2025
- Reporting period
- Oct 03, 2025
- Description
- Schedule 13G beneficial ownership